APH-0804

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug NameAPH-0804
Drug Alias NameTDP1 and TOP1 inhibitors (Aphios)APH-0804APH0804
ClassificationCell and gene therapy > Gene therapy > LNPSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA topoisomerase I inhibitorsTyrosyl-DNA phosphodiesterase 1 inhibitors
TargetsDNA topoisomerase ITyrosyl-DNA phosphodiesterase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAphios Corporation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAphios Corporation
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A